Higher vitamin B 12 from mid‐ to late life is related to slower rates of cognitive decline
Alzheimer's & Dementia · 2025
DOI: 10.1002/alz.70864 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Francesca R Marino und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Neurobiology, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Vitamin B 12, Cognitive Dysfunction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
INTRODUCTION Evidence is needed to evaluate whether low vitamin B 12 from mid‐ to late life, either alone or in the presence of elevated folate, is associated with cognitive decline. METHODS Participants from the Framingham Heart Study without baseline dementia who had ≥ 2 measures of a three‐component vitamin B 12 indicator (3cB 12 ) and neuropsychological factor scores were included ( n = 1994; mean age: 60 years). Adjusted linear mixed effects models estimated annual changes in each factor score between 3cB 12 quartiles. Interaction by folate status was also evaluated. RESULTS Participants in the highest 3cB 12 quartile had slower declines in memory, executive function, and language compared to the lowest quartile (memory: β = 0.0071, 95% confidence interval [CI] = 0.003–0.01; executive function: β = 0.0056, 95% CI = 0.0009–0.01; and language: β = 0.0090, 95% CI = 0.004–0.01). Findings were largely robust by folate status (elevated: ≥ 20 ng/mL; non‐elevated: 6–19 ng/mL). DISCUSSION Improving B 12 status in dementia‐free older adults may help mitigate cognitive decline into later life. Highlights Higher vitamin B 12 status is associated with slower annual cognitive decline. Higher B 12 was linked with 0.05 to 0.09 standard deviation less cognitive decline over 10 years. B 12 and memory findings are robust for elevated, not non‐elevated, folate status.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy and Neurobiology, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, USA.
- The Framingham Heart Study, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, USA.
- Department of Nutritional Sciences, Rutgers University, New Brunswick, New Jersey, USA.
- USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts, USA.
- Department of Neurology, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, USA.
- Alzheimer's Disease Research Center, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, USA.
ORCID-Profile: Francesca R Marino
Förderung
- NIA NIH HHS
- NIH HHS
- NHLBI NIH HHS
- CLC NIH HHS
- National Institutes of Health
- National Heart, Lung, and Blood Institute
- National Institute on Aging
Zitieren
APA
Marino, F. R., Rogers, G., Miller, J. W., Selhub, J., Mez, J., Crane, P. K., Mukherjee, S., Saykin, A. J., Hohman, T. J., Trittschuh, E. H., Au, R., Jacques, P. F., & Hwang, P. H. (2025). Higher vitamin B 12 from mid‐ to late life is related to slower rates of cognitive decline. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70864
Vancouver
Marino FR, Rogers G, Miller JW, Selhub J, Mez J, Crane PK, et al. Higher vitamin B 12 from mid‐ to late life is related to slower rates of cognitive decline. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70864
BibTeX
@article{Marino2025,
author = {Marino, Francesca R and Rogers, Gail and Miller, Joshua W and Selhub, Jacob and Mez, Jesse and Crane, Paul K and Mukherjee, Shubhabrata and Saykin, Andrew J and Hohman, Timothy J and Trittschuh, Emily H and Au, Rhoda and Jacques, Paul F and Hwang, Phillip H},
title = {Higher vitamin B 12 from mid‐ to late life is related to slower rates of cognitive decline},
journal = {Alzheimer's & Dementia},
year = {2025},
doi = {10.1002/alz.70864}
}
EUVIMED